National Center on Minority Health and Health Disparities; Notice of Meeting, 30954-30955 [05-10754]
Download as PDF
30954
Federal Register / Vol. 70, No. 103 / Tuesday, May 31, 2005 / Notices
products. We do not intend to make a
final decision on the proposed revision
of CPG 7132b.11 until we complete
further study of the expiration dating
issue to determine the most
scientifically sound approach. We invite
interested persons to submit data
establishing appropriate expiration
dating for such drug products.
This draft guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the agency’s current thinking
on expiration dating on nonsterile unitdose repackaged drug products. It does
not create or confer any rights for or on
any person and does not operate to bind
FDA or the public. An alternative
approach may be used if such approach
satisfies the current requirements of the
applicable statutes and regulations.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments on the draft guidance. Submit
a single copy of electronic comments or
two paper copies of any mailed
comments, except that individuals may
submit one paper copy. Comments are
to be identified with the docket number
found in brackets in the heading of this
document. The draft guidance and
received comments may be seen in the
Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday.
III. Electronic Access
Persons with access to the Internet
may obtain the documents at https://
www.fda.gov/cder/guidance/index.htm
or https://ohrms/dockets/default.htm.
Dated: May 19, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05–10702 Filed 5–27–05; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate jul<14>2003
16:14 May 27, 2005
Jkt 205001
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
A—Cancer Center.
Date: August 4–5, 2005.
Time: 7 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: David E. Maslow, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8117,
Bethesda, MD 20892–7405, (301) 496–2330,
dm65y@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 19, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–10755 Filed 5–27–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel Meeting Conflict.
Date: June 24, 2005.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH/NCCAM, Democracy II, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892.
Contact Person: Jeanette M. Hosseini,
Scientific Review Administrator, National
Center for Complementary and Alternative
Medicine, 6707 Democracy Blvd, Suite 401,
Bethesda, MD 20892, (301) 594–9096.
Dated: May 19, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–10753 Filed 5–27–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center on Minority Health and
Health Disparities; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Council on Minority
Health and Health Disparities.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities.
Date: June 21, 2005.
Open: 8:30 a.m. to 4 p.m.
Agenda: The agenda will include Opening
Remarks, Administrative Matters, Director’s
Report, NCMHD, National Academy of
Sciences Report on Assessment of NIH
Minority Research an Training Programs,
NIH IC Health Disparities Research Report,
NCMHD Program Highlights, other business
of the Council.
E:\FR\FM\31MYN1.SGM
31MYN1
Federal Register / Vol. 70, No. 103 / Tuesday, May 31, 2005 / Notices
Place: Gaitherburg Marriott Washingtonian
Center, 9751 Washingtonian Boulevard,
Gaithersburg, MD 20878.
Closed: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Donna Brooks, Asst.
Director for Administration, National Center
on Minority Health and Health Disparities,
National Institutes of Health, 6707
Democracy Blvd., Suite 800, Bethesda, MD
20892, 301–435–2135,
brooksd@ncmhd.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Dated: May 19, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–10754 Filed 5–27–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Eye Council.
The meeting will be open to the
public as indicated below with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council.
Date: June 9, 2005.
Open: 8:30 a.m. to 2:30 p.m.
Agenda: Following opening remarks by the
Director, NEI, there will be presentations by
VerDate jul<14>2003
16:14 May 27, 2005
Jkt 205001
30955
the staff of the Institute and discussions
concerning Institute programs.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Closed: 2:30 p.m. to 5 p.m.
Agenda: to review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Lore Anne McNicol, PhD,
Director, Division of Extramural Research,
National Eye Institute, National Institutes of
Health, Bethesda, MD 20892, (301) 451–2020.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nei.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Hotel, Inner Harbor,
300 Light Street, Baltimore, MD 21202.
Contact Person: Patricia A. Haggerty, PhD,
Section Chief, Clinical Studies and Training
Scientific Review Group, Review Branch,
Division of Extramural Affairs, National
Heart, Lung, and Blood Institute, NIH, 6701
Rockledge Drive, Room 7194, MSC 7924,
Bethesda, MD 20892, 301/435–0288,
haggert@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 19, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–10756 Filed 5–27–05; 8:45 am]
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group Clinical Trials
Review Committee.
Date: June 27–28, 2005.
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Dated: May 23, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–10745 Filed 5–27–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
R13 Conference Grants.
Date: July 1, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NHLBI, 6701 Rockledge II, Rockledge Drive,
Room 7100, Bethesda, MD 20892, (Telephone
Conference Call.)
Contact Person: Deborah P. Beebe, PhD,
Director, Division of Extramural Affairs,
National Heart, Lung, and Blood Institute,
NIH, 6701 Rockledge Drive, Room 7100,
Bethesda, MD 20892–7924, 301/435–0260.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
E:\FR\FM\31MYN1.SGM
31MYN1
Agencies
[Federal Register Volume 70, Number 103 (Tuesday, May 31, 2005)]
[Notices]
[Pages 30954-30955]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-10754]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center on Minority Health and Health Disparities; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Advisory Council on Minority Health and Health
Disparities.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Minority Health
and Health Disparities.
Date: June 21, 2005.
Open: 8:30 a.m. to 4 p.m.
Agenda: The agenda will include Opening Remarks, Administrative
Matters, Director's Report, NCMHD, National Academy of Sciences
Report on Assessment of NIH Minority Research an Training Programs,
NIH IC Health Disparities Research Report, NCMHD Program Highlights,
other business of the Council.
[[Page 30955]]
Place: Gaitherburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Closed: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Donna Brooks, Asst. Director for Administration,
National Center on Minority Health and Health Disparities, National
Institutes of Health, 6707 Democracy Blvd., Suite 800, Bethesda, MD
20892, 301-435-2135, brooksd@ncmhd.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Dated: May 19, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-10754 Filed 5-27-05; 8:45 am]
BILLING CODE 4140-01-M